Literature DB >> 14532005

The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.

Andrew E H Elia1, Peter Rellos, Lesley F Haire, Jerry W Chao, Frank J Ivins, Katja Hoepker, Duaa Mohammad, Lewis C Cantley, Stephen J Smerdon, Michael B Yaffe.   

Abstract

Polo-like kinases (Plks) perform crucial functions in cell-cycle progression and multiple stages of mitosis. Plks are characterized by a C-terminal noncatalytic region containing two tandem Polo boxes, termed the Polo-box domain (PBD), which has recently been implicated in phosphodependent substrate targeting. We show that the PBDs of human, Xenopus, and yeast Plks all recognize similar phosphoserine/threonine-containing motifs. The 1.9 A X-ray structure of a human Plk1 PBD-phosphopeptide complex shows that the Polo boxes each comprise beta6alpha structures that associate to form a 12-stranded beta sandwich domain. The phosphopeptide binds along a conserved, positively charged cleft located at the edge of the Polo-box interface. Mutations that specifically disrupt phosphodependent interactions abolish cell-cycle-dependent localization and provide compelling phenotypic evidence that PBD-phospholigand binding is necessary for proper mitotic progression. In addition, phosphopeptide binding to the PBD stimulates kinase activity in full-length Plk1, suggesting a conformational switching mechanism for Plk regulation and a dual functionality for the PBD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532005     DOI: 10.1016/s0092-8674(03)00725-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  335 in total

Review 1.  Functions and regulation of the Polo-like kinase Cdc5 in the absence and presence of DNA damage.

Authors:  Vladimir V Botchkarev; James E Haber
Journal:  Curr Genet       Date:  2017-08-02       Impact factor: 3.886

2.  PLK2 phosphorylation is critical for CPAP function in procentriole formation during the centrosome cycle.

Authors:  Jaerak Chang; Onur Cizmecioglu; Ingrid Hoffmann; Kunsoo Rhee
Journal:  EMBO J       Date:  2010-06-08       Impact factor: 11.598

3.  Regulation of the final stage of mitosis by components of the pre-replicative complex and a polo kinase.

Authors:  Hyungshin Yim; Raymond L Erikson
Journal:  Cell Cycle       Date:  2011-05-01       Impact factor: 4.534

4.  Plk1 regulates activation of the anaphase promoting complex by phosphorylating and triggering SCFbetaTrCP-dependent destruction of the APC Inhibitor Emi1.

Authors:  David V Hansen; Alexander V Loktev; Kenneth H Ban; Peter K Jackson
Journal:  Mol Biol Cell       Date:  2004-10-06       Impact factor: 4.138

5.  Independent modulation of the kinase and polo-box activities of Cdc5 protein unravels unique roles in the maintenance of genome stability.

Authors:  Hery Ratsima; Anne-Marie Ladouceur; Mirela Pascariu; Véronique Sauvé; Zeina Salloum; Paul S Maddox; Damien D'Amours
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

6.  Identification of a novel Wnt5a-CK1ɛ-Dvl2-Plk1-mediated primary cilia disassembly pathway.

Authors:  Kyung Ho Lee; Yoshikazu Johmura; Li-Rong Yu; Jung-Eun Park; Yuan Gao; Jeong K Bang; Ming Zhou; Timothy D Veenstra; Bo Yeon Kim; Kyung S Lee
Journal:  EMBO J       Date:  2012-05-18       Impact factor: 11.598

7.  Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo.

Authors:  Juping Yuan; Mourad Sanhaji; Andrea Krämer; Wolfgang Reindl; Matthias Hofmann; Nina-Naomi Kreis; Brigitte Zimmer; Thorsten Berg; Klaus Strebhardt
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

8.  Crystallization and preliminary X-ray diffraction studies on the human Plk1 Polo-box domain in complex with an unphosphorylated and a phosphorylated target peptide from Cdc25C.

Authors:  Begoña García-Alvarez; Sonia Ibañez; Guillermo Montoya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-03-25

Review 9.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

10.  Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin.

Authors:  Zhiguo Li; Yifan Kong; Longzhen Song; Qian Luo; Jinghui Liu; Chen Shao; Xianzeng Hou; Xiaoqi Liu
Journal:  Cancer Res       Date:  2018-03-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.